Endothelin-2 in Ovarian Follicle Rupture
Author(s) -
CheMyong Ko,
Mary C. Gieske,
Linah Al-Alem,
YunKyung Hahn,
Wen Su,
Ming Gong,
Marc Iglarz,
Yongbum Koo
Publication year - 2006
Publication title -
endocrinology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.2005-1228
Subject(s) - ovulation , follicle , medicine , endocrinology , ovarian follicle , ovary , follicular phase , gonadotropin , biology , gonadotropin releasing hormone antagonist , oocyte , gonadotropin releasing hormone , luteinizing hormone , hormone , microbiology and biotechnology , embryo
The ovulatory process is activated by a surge of LH, a pituitary gonadotropin, which initiates a cohort of dramatic changes in biochemical, physical, and gene expression in the ovary, leading to follicle rupture and oocyte release. Here we report the identification of endothelin-2 (EDN2) as a last moment-trigger of follicle rupture. In the ovary, EDN2 is exclusively and transiently expressed in the granulosa cells immediately before ovulation. Administration of EDN2 to the ovarian tissue induced rapid contraction, whereas addition of tezosentan, an endothelin receptor antagonist, diminishes the EDN2 effect. In vivo, treatment of tezosentan before ovulation substantially decreases gonadotropin-induced superovulation. As a target tissue of EDN2 action, we identified a layer of smooth muscle cells in the follicular wall of each follicle. Taken together, our data indicate that EDN2 induces follicular rupture by constricting periovulatory follicles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom